These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15650222)

  • 21. Vaccination of cats with attenuated feline immunodeficiency virus proviral DNA vaccine expressing gamma interferon.
    Gupta S; Leutenegger CM; Dean GA; Steckbeck JD; Cole KS; Sparger EE
    J Virol; 2007 Jan; 81(2):465-73. PubMed ID: 17079309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prime-boost vaccination using DNA and whole inactivated virus vaccines provides limited protection against virulent feline immunodeficiency virus.
    Dunham SP; Bruce J; Klein D; Flynn JN; Golder MC; MacDonald S; Jarrett O; Neil JC
    Vaccine; 2006 Nov; 24(49-50):7095-108. PubMed ID: 17049683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccine protection against feline immunodeficiency virus: setting the challenge.
    Zwijnenberg R; Yamamoto JK
    Aust Vet J; 2007 Jun; 85(6):210-1. PubMed ID: 17547630
    [No Abstract]   [Full Text] [Related]  

  • 24. Feline immunodeficiency virus (FIV) neutralization: a review.
    Hosie MJ; Pajek D; Samman A; Willett BJ
    Viruses; 2011 Oct; 3(10):1870-90. PubMed ID: 22069520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination protects against in vivo-grown feline immunodeficiency virus even in the absence of detectable neutralizing antibodies.
    Matteucci D; Pistello M; Mazzetti P; Giannecchini S; Del Mauro D; Zaccaro L; Bandecchi P; Tozzini F; Bendinelli M
    J Virol; 1996 Jan; 70(1):617-22. PubMed ID: 8523581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toward vaccination against feline leukemia virus and feline immunodeficiency virus infections.
    Osterhaus AD; Weijer K; Siebelink KH; Rimmelzwaan GF; Bosch ML
    J Am Vet Med Assoc; 1991 Nov; 199(10):1443-6. PubMed ID: 1666100
    [No Abstract]   [Full Text] [Related]  

  • 27. Accelerated viremia in cats vaccinated with recombinant vaccinia virus expressing envelope glycoprotein of feline immunodeficiency virus.
    Osterhaus AD; Tijhaar E; Huisman RC; Huisman W; Darby IH; Francis MJ; Rimmelzwaan GF; Siebelink KH
    AIDS Res Hum Retroviruses; 1996 Mar; 12(5):437-41. PubMed ID: 8882329
    [No Abstract]   [Full Text] [Related]  

  • 28. Antibody Responses in Cats Following Primary and Annual Vaccination against Feline Immunodeficiency Virus (FIV) with an Inactivated Whole-Virus Vaccine (Fel-O-Vax
    Westman M; Yang D; Green J; Norris J; Malik R; Parr YA; McDonald M; Hosie MJ; VandeWoude S; Miller C
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33809232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of virus burden by immunization with feline immunodeficiency virus Env protein.
    Hosie MJ; Dunsford TH; de Ronde A; Willett BJ; Cannon CA; Neil JC; Jarrett O
    Vaccine; 1996 Apr; 14(5):405-11. PubMed ID: 8735552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination.
    Flynn JN; Keating P; Hosie MJ; Mackett M; Stephens EB; Beatty JA; Neil JC; Jarrett O
    J Immunol; 1996 Oct; 157(8):3658-65. PubMed ID: 8871667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response of feral cats to vaccination at the time of neutering.
    Fischer SM; Quest CM; Dubovi EJ; Davis RD; Tucker SJ; Friary JA; Crawford PC; Ricke TA; Levy JK
    J Am Vet Med Assoc; 2007 Jan; 230(1):52-8. PubMed ID: 17199493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Removal of the cleavage site of recombinant feline immunodeficiency virus envelope protein facilitates incorporation of the surface glycoprotein in immune-stimulating complexes.
    Rimmelzwaan GF; Siebelink KH; Huisman RC; Moss B; Francis MJ; Osterhaus AD
    J Gen Virol; 1994 Aug; 75 ( Pt 8)():2097-102. PubMed ID: 8046415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preparation of the vaccine with inactivated Feline Panleukopenia Virus isolated from tiger and the preliminary application].
    Yu Y; Zhou M; Zhang J; Hua Y; Wang L; Liu Y; Liu D; Xia X
    Wei Sheng Wu Xue Bao; 2009 May; 49(5):643-7. PubMed ID: 19637573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats.
    Kusuhara H; Hohdatsu T; Okumura M; Sato K; Suzuki Y; Motokawa K; Gemma T; Watanabe R; Huang C; Arai S; Koyama H
    Vet Microbiol; 2005 Jul; 108(3-4):155-65. PubMed ID: 15899558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gag-specific immune enhancement of lentiviral infection after vaccination with an adenoviral vector in an animal model of AIDS.
    Klonjkowski B; Klein D; Galea S; Gavard F; Monteil M; Duarte L; Fournier A; Sayon S; Górna K; Ertl R; Cordonnier N; Sonigo P; Eloit M; Richardson J
    Vaccine; 2009 Feb; 27(6):928-39. PubMed ID: 19070641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Partial protection by vaccination with recombinant feline immunodeficiency virus surface glycoproteins.
    Leutenegger CM; Hofmann-Lehmann R; Holznagel E; Cuisinier AM; Wolfensberger C; Duquesne V; Cronier J; Allenspach K; Aubert A; Ossent P; Lutz H
    AIDS Res Hum Retroviruses; 1998 Feb; 14(3):275-83. PubMed ID: 9491919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations in feline immunodeficiency (FIV) virus envelope gene V3-V5 regions in FIV-infected cats.
    Motokawa K; Hohdatsu T; Imori A; Arai S; Koyama H
    Vet Microbiol; 2005 Mar; 106(1-2):33-40. PubMed ID: 15737471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: protection from an intraclade challenge administered systemically or mucosally by an attenuated vaccine.
    Pistello M; Matteucci D; Bonci F; Isola P; Mazzetti P; Zaccaro L; Merico A; Del Mauro D; Flynn N; Bendinelli M
    J Virol; 2003 Oct; 77(20):10740-50. PubMed ID: 14512524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA.
    Lockridge KM; Chien M; Dean GA; Stefano Cole K; Montelaro RC; Luciw PA; Sparger EE
    Virology; 2000 Jul; 273(1):67-79. PubMed ID: 10891409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual-subtype FIV vaccine (Fel-O-Vax FIV) protection against a heterologous subtype B FIV isolate.
    Pu R; Coleman J; Coisman J; Sato E; Tanabe T; Arai M; Yamamoto JK
    J Feline Med Surg; 2005 Feb; 7(1):65-70. PubMed ID: 15686976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.